Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

盐酸曲恩汀胶囊 - NMPA Drug Approval Details

Approvals/NMPA/Trientine Hydrochloride Capsules

Approved

化学药品

Trientine Hydrochloride Capsules

Navinta LLC🇨🇳 National Medical Products Administration

Approval Date: Aug 27, 2024
Approval ID: 8cyabl0bx3H
Company: Navinta LLC
Type: 化学药品

Approval Details

Approval Id: 8cyabl0bx3H
Approval Number: 国药准字HJ20240087
Generic Name: 盐酸曲恩汀胶囊
Generic Name En: Trientine Hydrochloride Capsules
Drug Type: 化学药品
Dosage Form: 胶囊剂
Strength: 250mg（以C₆H₁₈N₄·2HCl计）
Reg Date: 2024-08-27
Expired Date: 2029-08-26
Company Name: Navinta LLC
Company Detail Path: /organization/navinta-llc

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Aug 27, 2024

Approval ID

8cyabl0bx3H

Type

化学药品

Back to NMPA Approvals